Monoclonal gammopathies of undetermined significance

Hematology/Oncology Clinics of North America

Volumn 13, Issue 6, 1999, Pages 1181-1202

  Kyle, Robert A ^b   Rajkumar, S Vincent ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; M PROTEIN;

AMYLOIDOSIS; DISEASE COURSE; HUMAN; MACROGLOBULINEMIA; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOPROLIFERATIVE DISORDER; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; REVIEW;

EID: 0033371853     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70120-9     Document Type: Article

References (111)

1. R. Alexanian Monoclonal gammopathy in lymphoma Arch Intern Med 135 1975 62
2. P. Andreone A.L. Zignego C. Cursaro Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection Ann Intern Med 129 1998 294
3. T.M. Annesley M.F. Burritt R.A. Kyle Artifactual hypercalcemia in multiple myeloma Mayo Clin Proc 57 1982 572
4. U. Axelsson A 20-year follow-up study of 64 subjects with M-components Acta Medica Scandinavica 219 1986 519
5. U. Axelsson R. Bachmann J. Hallen Frequency of pathological proteins (M-components) in 6,995 sera from an adult population Acta Medica Scandinavica 179 1966 235
6. H.A. Azar W.T. Hill E.F. Osserman Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins Am J Med 23 1957 239
7. A.D. Badley D.F. Portela R. Patel Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder Liver Transpl Surg 2 1996 375
8. L. Baldini A. Guffanti B.M. Cesana Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy Blood 87 1996 912
9. P.A. Bardwick N.J. Zvaifler G.N. Gill Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome Report on two cases and a review of the literature. Medicine (Baltimore) 59 1980 311
10. R. Bataille M. Jourdan X.G. Zhang Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias J Clin Invest 84 1989 2008
11. L. Bellaïche J.D. Laredo F. Lioté Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma Spine 22 1997 2551
12. J. Bladé R.A. Kyle IgD monoclonal gammopathy with long-term follow-up Br J Haematol 88 1994 395
13. J. Bladé A. López-Guillermo C. Rozman Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance Br J Haematol 81 1992 391
14. M. Bowden J. Crawford H.J. Cohen A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly J Am Geriatr Soc 41 1993 11
15. K. Brady L. Corash V. Bhargava Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease Arch Pathol Lab Med 121 1997 1108
16. G.F. Buezo J.I. Porras J. Fraga Coexistence of diffuse plane normolipaemic xanthoma and amyloidosis in a patient with monoclonal gammopathy Br J Dermatol 135 1996 460
17. A. Carter I. Tatarsky The physiopathological significance of benign monoclonal gammopathy: A study of 64 cases Br J Haematol 46 1980 565
18. G. Castaman F. Rodeghiero E. Di Bona Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy Blut 58 1989 211
19. B. Chassande J.M. Leger A.B. Younes-Chennoufi Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases Muscle Nerve 21 1998 55
20. H.J. Cohen J. Crawford M.K. Rao Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly Am J Med 104 1998 439
21. J. Crawford M.K. Eye H.J. Cohen Evaluation of monoclonal gammopathies in the “well” elderly Am J Med 82 1987 39
22. M.C. Dalakas I. Illa E. Gallardo Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlations Ann Neurol 41 1997 100
23. G. Dighiero B. Guilbert J.P. Fermand Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: Immunologic studies and clinical correlations Blood 62 1983 264
24. J. Drach J. Angerler J. Schuster Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance Blood 86 1995 3915
25. U. Dührsen M. Uppenkamp P. Meusers Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias Blut 56 1988 97
26. P.J. Dyck P.A. Low A.J. Windebank Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance N Engl J Med 325 1991 1482
27. T. Economopoulos J. Economidou G. Giannopoulos Immune abnormalities in myelodysplastic syndromes J Clin Pathol 38 1985 908
28. J.M. Faed B. Day M. Pollock High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy Neurology 39 1989 422
29. M. Farhangi E.F. Osserman Myeloma with xanthoderma due to an IgGλ monoclonal anti-flavin antibody N Engl J Med 294 1976 177
30. M.C. Finan R.K. Winkelmann Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases Medicine (Baltimore) 65 1986 376
31. J.M. Fine P. Lambin J.Y. Muller The evolution of asymptomatic monoclonal gammopathies. A follow-up of 20 cases over periods of 3–14 years Acta Medica Scandinavica 205 1979 339
32. J.A. Gelfand G.R. Boss C.L. Conley Acquired C1 esterase inhibitor deficiency and angioedema: A review Medicine (Baltimore) 58 1979 321
33. F. Ginevri A. Nocera L. Bonato Cytomegalovirus infection is a trigger for monoclonal immunoglobulins in paediatric kidney transplant recipients Transplant Proc 30 1998 2079
34. M.P. Giraldo D. Rubio-Felix M. Perella Monoclonal gammopathies of undetermined significance Clinical course and biological aspects of 397 cases [Spanish]. Sangre (Barc) 36 1991 377
35. G.J. Goldenberg F. Paraskevas L.G. Israels The association of rheumatoid arthritis with plasma cell and lymphocytic neoplasms Arthritis Rheum 12 1969 569
36. P.R. Greipp T.E. Witzig N.J. Gonchoroff Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies Mayo Clin Proc 62 1987 969
37. B. Grosbois P. Jégo H. de Rosa Triclonal gammopathy and malignant immunoproliferative syndrome [French] Rev Med Interne 18 1997 470
38. D.A. Hafler D. Johnson J.J. Kelly Monoclonal gammopathy and neuropathy: Myelin-associated glycoprotein reactivity and clinical characteristics Neurology 36 1986 75
39. L. Hammarström C.I. Smith Frequent occurrence of monoclonal gammopathies with an imbalanced light-chain ratio following bone marrow transplantation Transplantation 43 1987 447
40. D.A. Hansen B.A. Robbins D.J. Bylund Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia Am J Clin Pathol 102 1994 580
41. H. Hebart H. Einsele R. Klein CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies Br J Haematol 95 1996 138
42. M. Heer H. Joller-Jemelka A. Fontana Monoclonal gammopathy in chronic active hepatitis Liver 4 1984 255
43. T. Isobe E.F. Osserman Pathologic conditions associated with plasma cell dyscrasias: A study of 806 cases Ann N Y Acad Sci 190 1971 507
44. K. James H. Fudenberg W.L. Epstein Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus) Clin Exp Immunol 2 1967 153
45. J.A. Katzmann R. Clark E. Sanders Prospective study of serum protein capillary zone electrophoresis and immunotyping of monoclonal proteins by immunosubtraction Am J Clin Pathol 110 1998 503
46. J.J. Kelly L.S. Adelman E. Berkman Polyneuropathies associated with IgM monoclonal gammopathies Arch Neurol 45 1988 1355
47. J.J. Kelly Jr R.A. Kyle J.M. Miles Osteosclerotic myeloma and peripheral neuropathy Neurology 33 1983 202
48. J.J. Kelly Jr R.A. Kyle P.C. O'Brien Prevalence of monoclonal protein in peripheral neuropathy Neurology 31 1981 1480
49. P.M. Kövary L. Suter E. Macher Monoclonal gammopathies in Sézary syndrome: A report of four new cases and a review of the literature Cancer 48 1981 788
50. R.A. Kyle Monoclonal gammopathy of undetermined significance. Natural history in 241 cases Am J Med 64 1978 814
51. R.A. Kyle `Benign' monoclonal gammopathy A misnomer? JAMA 251 1984 1849
52. R.A. Kyle “Benign” monoclonal gammopathy–after 20 to 35 years of follow-up Mayo Clin Proc 68 1993 26
53. R.A. Kyle Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma Hematol Oncol Clin North Am 11 1997 71
54. R.A. Kyle Sequence of testing for monoclonal gammopathies Arch Pathol Lab Med 123 1999 114
55. R.A. Kyle E.D. Bayrd B.F. McKenzie Diagnostic criteria for electrophoretic patterns of serum and urinary proteins in multiple myeloma: Study of one hundred and sixty-five multiple myeloma patients and of seventy-seven nonmyeloma patients with similar electrophoretic patterns JAMA 174 1960 245
56. R.A. Kyle C.M. Beard W.M. O'Fallon Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945 J Clin Oncol 12 1994 1577
57. R.A. Kyle S. Finkelstein L.R. Elveback Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma Blood 40 1972 719
58. R.A. Kyle J.P. Garton The spectrum of IgM monoclonal gammopathy in 430 cases Mayo Clin Proc 62 1987 719
59. R.A. Kyle P.R. Greipp Smoldering multiple myeloma N Engl J Med 302 1980 1347
60. R.A. Kyle P.R. Greipp “Idiopathic” Bence Jones proteinuria: Long-term follow-up in seven patients N Engl J Med 306 1982 564
61. R.A. Kyle J.A. Katzmann Immunochemical characterization of immunoglobulins N.R. Rose Conway de Macario E. Folds J.D. Manual of Clinical Laboratory Immunology ed 5 1997 ASM Press Washington, DC 156
62. R.A. Kyle J.E. Maldonado E.D. Bayrd Idiopathic Bence Jones proteinuria–a distinct entity? Am J Med 55 1973 222
63. R.A. Kyle R.A. Robinson J.A. Katzmann The clinical aspects of biclonal gammopathies. Review of 57 cases Am J Med 71 1981 999
64. R.A. Kyle T.E. Witzig Monoclonal gammopathies of undetermined significance P.H. Wiernik G.P. Canellos J.P. Dutcher Neoplastic Diseases of the Blood ed 3 1996 Churchill Livingstone New York 679
65. M.Q. Lacy K.A. Donovan J.K. Heimbach Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma Blood 93 1999 300
66. M. Laroche M. Attal C. Dromer Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma Clin Rheumatol 15 1996 347
67. J.J. Lefrére M. Debbia P. Lambin Prospective follow-up of monoclonal gammopathies in HIV-infected individuals Br J Haematol 84 1993 151
68. G.J. Ligthart J. Radl J.X. Corberand Monoclonal gammopathies in human aging: Increased occurrence with age and correlation with health status Mech Ageing Dev 52 1990 235
69. F.D. Lindström U. Dahlstrom Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases Clin Immunol Immunopathol 10 1978 168
70. M.E. Lutz M.S. Daoud M.T. McEvoy Subcorneal pustular dermatosis: A clinical study of ten patients Cutis 61 1998 203
71. M.J. Mant J. Hirsh J. Gauldie Von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy Blood 42 1973 429
72. N.F. Martin M.C. Kincaid W.J. Stark Ocular copper deposition associated with pulmonary carcinoma, IgG monoclonal gammopathy and hypercupremia. A clinicopathologic correlation Ophthalmology 90 1983 110
73. H. Matsuzaki K. Yamaguchi T. Kagimoto Monoclonal gammopathies in adult T-cell leukemia Cancer 56 1985 1380
74. DOT I. Biochemical and functional characterization Mol Immunol 27 1990 385
75. G. Merlini M. Farhangi E.F. Osserman Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias Semin Oncol 13 1986 350
76. G. Merlini L.A. Fitzpatrick E.S. Siris A human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia J Clin Immunol 4 1984 185
77. P. Noel R.A. Kyle Monoclonal proteins in chronic lymphocytic leukemia Am J Clin Pathol 87 1987 385
78. M.L. O'Connor D.T. Rice D.H. Buss Immunoglobulin D benign monoclonal gammopathy. A case report Cancer 68 1991 611
79. M. Ocqueteau A. Orfao J. Almeida Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma Am J Pathol 152 1998 1655
80. G.P. Pageaux A. Bonnardet M.C. Picot Prevalence of monoclonal immunoglobulins after liver transplantation: Relationship with posttransplant lymphoproliferative disorders Transplantation 65 1998 397
81. G. Paladini M. Fogher G. Mazzanti Idiopathic monoclonal gammopathy. Long-term study of 313 cases [Italian] Recenti Prog Med 80 1989 123
82. M. Pascual S. Mach-Pascual J.A. Schifferli Paraproteins and complement depletion: Pathogenesis and clinical syndromes Semin Hematol 34 suppl 1 1997 40
83. P. Pasqualetti R. Casale Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance Biomed Pharmacother 51 1997 74
84. M.C. Perry R.A. Kyle The clinical significance of Bence Jones proteinuria Mayo Clin Proc 50 1975 234
85. T. Pettersson L. Hortling A.M. Teppo Phosphate binding by a myeloma protein Acta Medica Scandinavica 222 1987 89
86. H. Pham A. Lemoine M. Salvucci Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression Liver Transpl Surg 4 1998 146
87. M. Pizzolato G. Bragantini P. Bresciani IgG1-kappa biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism Br J Haematol 102 1998 503
88. F.C. Powell A.L. Schroeter W.P. Su Pyoderma gangrenosum and monoclonal gammopathy Arch Dermatol 119 1983 468
89. P.W. Pratt S. Kochwa S. Estren Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases Blood 31 1968 633
90. L.E. Probst E. Hoffman M.G. Cherian Ocular copper deposition associated with benign monoclonal gammopathy and hypercupremia Cornea 15 1996 94
91. J. Radl R.M. Valentijn J.J. Haaijman Monoclonal gammopathies in patients undergoing immunosuppressive treatment after renal transplantation Clin Immunol Immunopathol 37 1985 98
92. E. Renoult F. Bertrand M. Kessler Monoclonal gammopathies in HbsAg-positive patients with renal transplants [letter] N Engl J Med 318 1988 1205
93. P.G. Riches J. Sheldon A.M. Smith Overestimation of monoclonal immunoglobulin by immunochemical methods Ann Clin Biochem 28 1991 253
94. A.H. Ropper K.C. Gorson Neuropathies associated with paraproteinemia N Engl J Med 338 1998 1601
95. M. Rovira F. Cervantes B. Nomdedeu Chronic neutrophilic leukaemia preceding for seven years the development of multiple myeloma Acta Haematol 83 1990 94
96. C. Sakashita T. Saito T. Kurosu Two M-components in a single cell lineage in a patient with a dual isotype secretory B-cell tumour Br J Haematol 102 1998 791
97. J.P. Saleun M. Vicariot P. Deroff Monoclonal gammopathies in the adult population of Finistere, France J Clin Pathol 35 1982 63
98. L.Y. Shih P. Dunn W.M. Leung Localised plasmacytomas in Taiwan: Comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone Br J Cancer 71 1995 128
99. Y. Shoenfeld S. Berliner J. Pinkhas The association of Gaucher's disease and dysproteinemias Acta Haematol 64 1980 241
100. D. Simovic K.C. Gorson A.H. Ropper Comparison of IgM-MGUS and IgG-MGUS polyneuropathy Acta Neurol Scand 97 1998 194
101. M. Sonnenblick U. Eylath R. Brisk Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma Clin Chem 32 1986 1537
102. E. Soppi J. Eskola M. Röyttä Thymoma with immunodeficiency (Good's syndrome) associated with myasthenia gravis and benign IgG gammopathy Arch Intern Med 145 1985 1704
103. G. Touchard T. Pasdeloup J. Parpeix High prevalence and usual persistence of serum monoclonal immunoglobulins evidenced by sensitive methods in renal transplant recipients Nephrol Dial Transplant 12 1997 1199
104. P.Y. Venencie R.K. Winkelmann S.J. Friedman Monoclonal gammopathy and mycosis fungoides. Report of four cases and review of the literature J Am Acad Dermatol 11 1984 576
105. P.Y. Venencie R.K. Winkelmann A. Puissant Monoclonal gammopathy in Sézary syndrome. Report of three cases and review of the literature Arch Dermatol 120 1984 605
106. C. Vital A. Vital C. Deminiere Myelin modifications in 8 cases of peripheral neuropathy with Waldenström's macroglobulinemia and anti-MAG activity Ultrastruct Pathol 21 1997 509
107. T.E. Witzig R.A. Kyle P.R. Greipp Circulating peripheral blood plasma cells in multiple myeloma Curr Top Microbiol Immunol 182 1992 195
108. T.E. Witzig R.A. Kyle W.M. O'Fallon Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma Br J Haematol 87 1994 266
109. M. Zandecki V. Obein F. Bernardi Monoclonal gammopathy of undetermined significance: Chromosome changes are a common finding within bone marrow plasma cells Br J Haematol 90 1995 693
110. Z.A. Zawadzki T.G. Benedek Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia Arthritis Rheum 12 1969 555
111. C.S. Zent C.S. Wilson G. Tricot Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation Blood 91 1998 3518